StockData
Bruker Corp logo

Bruker Corp (BRKR) stock

BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30307% above fair value
$63.26+1.90 (+3.10%)

Close on Nov 18, 2026Market cap $9.81BP/E –Yield –

Bruker shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Bruker's shares outstanding was 152M at Jun 30, 2026. For fiscal 2025 it was 152M, up 1.5% from the year before. Over ten years it grew -1.1% a year on average. The highest annual figure on record is 170M in fiscal 2014.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025152M+1.5%
FY2024Dec 31, 2024150M+1.6%
FY2023Dec 31, 2023147M+98527343.1%
FY2022Dec 31, 20220M-2.3%
FY2021Dec 31, 20210M-1.1%
FY2020Dec 31, 20200M-1.3%
FY2019Dec 31, 20190M-100.0%
FY2018Dec 31, 2018157M-1.2%
FY2017Dec 31, 2017159M-1.9%
FY2016Dec 31, 2016162M-4.1%
FY2015Dec 31, 2015169M-0.2%
FY2014Dec 31, 2014170M+0.6%
FY2013Dec 31, 2013169M+0.7%
FY2012Dec 31, 2012167M+0.3%
FY2011Dec 31, 2011167M+0.7%
FY2010Dec 31, 2010166M+0.5%
FY2009Dec 31, 2009165M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026152M+0.4%
Q1 FY2026Mar 31, 2026153M+0.5%
Q4 FY2025Dec 31, 2025152M+0.1%
Q3 FY2025Sep 30, 2025152M-0.1%
Q2 FY2025Jun 30, 2025152M+2.5%
Q1 FY2025Mar 31, 2025152M+104112305.8%
Q4 FY2024Dec 31, 2024152M+103122778.5%
Q3 FY2024Sep 30, 2024152M+102911206.7%
Q2 FY2024Jun 30, 2024148M+100270902.7%
Q1 FY2024Mar 31, 20240M-1.4%
Q3 FY2023Sep 30, 20230M-0.9%
Q2 FY2023Jun 30, 20230M-1.4%
Q1 FY2023Mar 31, 20230M-2.5%
Q4 FY2022Dec 31, 20220M-3.1%
Q3 FY2022Sep 30, 20220M-2.7%
Q2 FY2022Jun 30, 20220M-2.0%
Q1 FY2022Mar 31, 20220M-1.2%
Q4 FY2021Dec 31, 20210M-100.0%
Q3 FY2021Sep 30, 20210M-100.0%
Q2 FY2021Jun 30, 20210M-100.0%
Q1 FY2021Mar 31, 20210M-100.0%
Q3 FY2020Sep 30, 2020154M-2.1%
Q2 FY2020Jun 30, 2020155M-2.0%
Q1 FY2020Mar 31, 2020155M-1.1%
Q3 FY2019Sep 30, 2019156M-1.1%
Q2 FY2019Jun 30, 2019158M+0.4%
Q1 FY2019Mar 31, 2019158M+0.6%
Q4 FY2018Dec 31, 2018157M+0.3%
Q3 FY2018Sep 30, 2018157M-0.8%
Q2 FY2018Jun 30, 2018157M-2.1%
Q1 FY2018Mar 31, 2018157M-2.2%
Q4 FY2017Dec 31, 2017157M-2.5%
Q3 FY2017Sep 30, 2017159M-1.7%
Q2 FY2017Jun 30, 2017160M–
Q1 FY2017Mar 31, 2017161M–
Q4 FY2016Dec 31, 2016161M–
Q3 FY2016Sep 30, 2016162M–

More Bruker figures

See a number that looks wrong?